Chronic mitochondrial inhibition induces selective motoneuron death in vitro: A new model for amyotrophic lateral sclerosis

Journal of Neurochemistry

Volumn 74, Issue 3, 2000, Pages 1158-1165

  Kaal, Evert C A ^a   Vlug, Angela S ^a   Versleijen, Michelle W J ^a   Kuilman, Maja ^a   Joosten, Elbert A J ^a   Bär, P R Dop ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; Apoptosis; Caspases; Malonate; Mitochondria

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ADENOSINE TRIPHOSPHATE; CASPASE; CYTOCHROME C OXIDASE; KETONE DERIVATIVE; MALONIC ACID; N TERT BUTYL ALPHA PHENYLNITRONE; RILUZOLE; SODIUM AZIDE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; MITOCHONDRIAL RESPIRATION; MOTONEURON; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ANIMALIA;

EID: 0033974440     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.741158.x     Document Type: Article

References (55)

1. Adams J. C. (1981) Heavy metal intensitication of DAB-based HRP reaction product. J. Histochem. Cytochem. 29, 775-780.
2. Al-Chalabi A., Powell J. F., and Leigh P. N. (1995) Neurofilaments, free radicals, excitotoxins, and amyotrophic lateral sclerosis. Muscle Nerve 18, 540-545.
3. Alexianu M. E., Ho B. K., Mohamed A. H., Labella V., Smith R. G., and Appel S. H. (1994) The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclero-sis. Ann. Neurol. 36, 846-858.
4. Baimbridge K. G., Celio M. R., and Rogers J. H. (1992) Calcium-binding proteins in the nervous system. Trends Neurosci. 15, 303-308.
5. Beal M. F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211-223.
6. Beal M. F., Ferrante R. J., Browne S. E., Matthews R. T., Kowall N. W., and Brown R. H. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42, 644-654.
7. Bensimon G., Leigh P. N., Guillet P., Powe L., Durrleman S., Delumeau J. C., Meininger V., Puech A. J., Whitehead J., Asselain B., Cesaro P., Larrey D., Rossor M., Zimmerman H. I., Salzman P., Doppler V., Lloyd C. M., Maloteaux J. M., Delwaide C., Laterre E. C., Bouchard J. P., Duquette P., Girard M., Masse C., Eisen A., Blin O., Azulay J. P., Billeturc F., Pouget J., Bouche P., Camu M., Carlander B., Billiard M., Clanet M., Angibaud G., Arnebes M. C., Benazet M., Couratier P., Vallat J. M., Desnuelle C., Lagueny A., Ellie E., Dib M., Rozier A., Salachas F., Viader F., Delaunay D., and Dengler R. (1996) A confirmatory doseranging study of riluzole in ALS. Neurology 47, S242-S250.
8. Bolaños J. P., Heales S. J. R., Land J. M., and Clark J. B. (1995) Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64, 1965-1972.
9. Browne S. E., Bowling A. C., Baik M. J., Gurney M., Brown R. H. Jr., and Beal M. F. (1998) Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J. Neurochem. 71, 281-287.
10. 2+ dependent. Neuroreport 6, 945-948.
11. Cassarino D. S. and Bennett J. P. Jr. (1999) An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Brain Res. Rev. 29, 1-25.
12. Cohen G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16.
13. Couratier P., Sindou P., Esclaire F., Louvel E., and Hugon J. (1994) Neuroprotective effects of riluzole in ALS CSF toxicity. Neuroreport 5, 1012-1014.
14. Curti D., Malaspina A., Facchetti G., Camana C., Mazzini L., Tosca P., Zerbi F., and Ceroni M. (1996) Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in periph-eral blood lymphocytes. Neurology 47, 1060-1064.
15. Doble A. (1996) The pharmacology and mechanism of action of riluzole. Neurology 47, S233-S241.
16. Friedlander R. M., Brown R. H., Gagliardini V., Wang J., and Yuan J. (1997) Inhibition of ICE slows ALS in mice. Nature 388, 31.
17. Fujita K., Yamauchi M., Shibayama K., Ando M., Honda M., and Nagata Y. (1996) Decreased cylochrome c oxidase activity but unchanged Superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis. J. Neurosci. Res. 45, 276-281.
18. Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281, 1309-1312.
19. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., and Hall E. D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
20. Henneberry R. C. (1997) Excitotoxicity as a consequence of impairment of energy metabolism: the energy-linked excitotoxic hypothesis, in Mitochondria and Free Radicals in Neurodegenerative Diseases (Beal M. F., Bodis-Wollner I., and Howel N., eds), pp. 111-143. Wiley-Liss, New York.
21. Herpers B. L., Schrama L. H., Kaal E. C. A., Joosten E. A. J., and Bär P. R. (1999) Microinjection of catalase cDNA prevents hydrogen peroxide-induced motoneuron death. Neuroreport 10, 1-4.
22. Hirsch T., Marchetti P., Susin S. A., Dallaporta B., Zamzami N., Marzo I., Geuskens M., and Kroemer G. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573-1581.
23. Kaal E. C. A., Joosten E. A. J., and Bär P. R. (1997) Prevention of apoptotic motoneuron death in vitro by neurotrophins and muscle extract. Neurochem. Int. 31, 193-201.
24. Kaal E. C. A., Veldman H., Sodaar P., Joosten E. A. J., and Bär P. R. (1998a) Oxidant treatment causes a dose-dependent phenotype of apoptosis in cultured motoneurons. J. Neurosci. Res. 54, 778-786.
25. Kaal E. C. A., Vlug A. S., Roelandse M. J. L., Joosten E. A. J., and Bär P. R. (1998b) Chronic mitochondrial inhibition induces selective motoneuron death in vitro. Soc. Neurosci. Abstr. 24, 1791.
26. Kerr J. F., Gobe G. C., Winterford C. M., and Harman B. V. (1995) Anatomical methods in cell death, in Methods in Cell Biology: Cell Death (Schwartz L. M. and Osborne B. A., eds), pp. 1-27. Academic Press, San Diego.
27. Koh J. Y., Kim D. K., Hwang J. Y., Kim Y. H., and Seo J. H. (1999) Antioxidative and proapoptotic effects of riluzole on cultured cortical neurons. J. Neurochem. 72, 716-723.
28. Lemaire C., Andreau K., Souvannavong V., and Adam A. (1998) Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett. 425, 266-270.
29. Martin D., Thompson M. A., and Nadler J. V. (1993) The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur. J. Pharmacol. 250, 473-476.
30. Martin L. J. (1999) Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 58, 459-471.
31. Marzo I., Brenner C., Zamzami N., Susin S. A., Beutner G., Brdiczka D., Remy R., Xie Z. H., Reed J. C., and Kroemer G., (1998) The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 187, 1261-1271.
32. McLaughlin B. A., Nelson D., Silver I.A., Erecinska M., and Chesselet M. F. (1998) Methylmalonate toxicity in primary neuronal cultures. Neuroscience 86, 279-290.
33. Mu X. J., He J., Anderson D. W., Trojanowski J. Q., and Springer J. E. (1996) Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40, 379-386.
34. Nakano Y., Hirayama K., and Terao K. (1987) Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch. Neurol 44, 103-106.
35. Obrenovitch T. P. (1998) Amyotrophic lateral sclerosis, excitotoxicity and riluzole. Trends Pharmacol. Sc. 19, 9-11.
36. Pellegrini-Giampietro D. E., Gorter J. A., Bennett M. V., and Zukin R. S. (1997) The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci. 20, 464-470.
37. Peluffo H., Estevez A., Barbeito L., and Stutzmann J. M. (1997) Riluzole promotes survival of rat motoneurons in vitro by stimulating trophic activity produced by spinal astrocyle monolayers. Neurosci. Lett. 228, 207-211.
38. Ren K. and Ruda M. A. (1994) A comparative study of the calcium-binding proteins calbindin-D28K, calretinin, calmodulin and parvalbumin in the rat spinal cord. Brain Res. Brain Res. Rev. 19, 163-179.
39. Rothstein J. D. (1996) Excitotoxicity hypothesis. Neurulogy 47, S19-S25.
40. Rothstein J. D. and Kuncl R. W. (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem. 65, 643-651.
41. Rothstein J. D., Jin L., Dykes-Hoberg M., and Kuncl R. W. (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90, 6591-6595.
42. Roy J., Minotti S., Dong L., Figlewicz D. A., and Durham H. D. (1998) Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms. J. Neurosci. 18, 9673-9684.
43. Sasaki S. and Iwata M. (1996) Impairment of fast axonal transpart in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 47, 535-540.
44. Schulz J. B., Matthews R. T., Henshaw D. R., and Beal M. F. (1996) Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases. Neuroscience 71, 1043-1048.
45. Shaw P. J., Ince P. G., Falkous G., and Mantle D. (1995) Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol. 38, 691-695.
46. Shoulson I. (1998) Experimental therapeutics of neurodegenerative disorders: unmet needs. Science 282, 1072-1074.
47. Siklos L., Engelhardt J., Harati Y., Smith R. G., Joo F., and Appel S. H. (1996) Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann. Neurol. 39, 203-216.
48. Smith R. G., Siklos L., Alexianu M. E., Engelhardt J. I., Mosier D. R., Colom L., Habib Mohamad A. and Appel S. H. (1996) Autoimmunity and ALS. Neurology 47 (Suppl. 2). S40-S45.
49. Swerdlow R. H., Parks J. K., Cassarino D. S., Trimmer P. A., Miller S. W., Maguire D. J., Sheehan J. P., Maguire R. S., Puttee G., Juel V. C., Phillips L. H., Tuttle J. B., Bennett J. P. Jr., Davis R. E., and Parker W. D., Jr. (1998) Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 153, 135-142.
50. Troost D., Aten J., Morsink F., and de Jong J. M. (1995) Apoptosis in amyotraphic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus. Neuropathol. Appl. Neurobiol. 21, 498-504.
51. Vandenberghe W., Van den Bosch L., and Robberecht W. (1998) Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system. Brain Res. 807, 1-10.
52. Vanning T., Drejer J., Frandsen A., and Schousboe A. (1996) Characterization of a chemical anoxia model in cerebellar granule neurons using sodium azide: protection by nifedipine and MK-801. J. Neurosci. Res. 44, 40-46.
53. Williams T. L., Day N. C., Ince P. G., Kamboj R. K., and Shaw P. J. (1997) Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxa/ole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 42, 200-207.
54. Yoshiyama Y., Yamada T., Asanuma K., and Asahi T. (1994) Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 88, 207-211.
55. Zeevalk G. D., Derr-Yellin E., and Nicklas W. J. (1995) Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J. Pharmacol. Exp. Ther. 275, 1124-1130.